CSWC
Capital Southwest Corporation
CSWC's fundamentals are mixed, but it looks expensive: trading at 14x earnings, above its usual 11x. Analysts expect earnings to hold roughly steady.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CSWC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
CSWC's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CSWC.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CSWC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9x | $15.26 | -35% |
| Forward | 9.8x | $23.50 | — |
| Fair | 11x | $18.28 | -22% |
| Current | 14x | $23.50 | — |
| Expensive | 15x | $25.07 | +6.7% |
Historical ranges are pointers, not guarantees.
CSWC's PE is in its expensive range at 14x. On analysts' estimates for next year's earnings, today's price would be 9.8x, in its fair range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CSWC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect CSWC's revenue to grow, but its profitability to weaken.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CSWC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.39 | +41% |
| Q3 2026 | $1.70 | +5.6% |
| Q2 2026 | $1.81 | -1.1% |
| Q1 2026 | $1.90 | -4% |
| Q4 2025 | $1.81 | -21% |
| Q3 2025 | $1.61 | -39% |
| Q2 2025 | $1.83 | -32% |
| Q1 2025 | $1.98 | -27% |
| Q4 2024 | $2.30 | -14% |
CSWC has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CSWC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $13.9M | -44% |
| Q1 2022 | $30M | +49% |
| Q4 2021 | $23.7M | -12% |
| Q3 2021 | $24.1M | -6.4% |
| Q2 2021 | $25.1M | +42% |
| Q4 2020 | $26.9M | +374% |
IREN has the stronger quarterly revenue trend. Revenue is down 44% for CSWC versus down 5.1% for IREN.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 29% | -35 points |
| Q1 2022 | 70% | +13 points |
| Q4 2021 | 56% | -9.4 points |
| Q3 2021 | -13% | -79 points |
| Q2 2021 | 64% | +8.6 points |
| Q1 2021 | 56% | N/A |
| Q4 2020 | 65% | +108 points |
| Q3 2020 | 66% | N/A |
CSWC's operating margin was 29% last quarter, down 35 points from the same quarter a year ago.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CSWC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$193.1M | -$121.8M |
| Q2 2026 | -$80.9M | -366% |
| Q1 2026 | -$59.2M | -$64K |
| Q4 2025 | -$93.6M | +$72.9M |
| Q3 2025 | -$71.3M | -$47M |
| Q2 2025 | $30.4M | -2.4% |
| Q1 2025 | -$59.1M | +$43M |
| Q4 2024 | -$166.6M | -1025% |
CSWC's free cash flow was −$427M over the past year, against −$267M the year before. Free cash flow isn't a meaningful measure for financial services companies like CSWC.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN has the edge over CSWC on cash flow, with more consistent year-over-year improvement.
CSWC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +2.5M shares |
| 1 year | +13% | +8.2M shares |
| 3 years | +84% | +33.3M shares |
| 5 years | +224% | +50.5M shares |
| Available history | +304% | +54.9M shares |
CSWC has 73M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $236,000 |
| Q3 2020 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over CSWC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CSWC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 15.0x | High |
| Q1 2022 | 10.5x | High |
| Q4 2021 | 12.3x | High |
| Q3 2021 | 10.1x | High |
| Q2 2021 | 6.8x | High |
| Q1 2021 | 6.1x | High |
| Q4 2020 | 15.6x | High |
| Q3 2020 | 215.5x | High |
CSWC's net debt is about 15 years of its operating earnings (EBITDA), up from 6.8 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CSWC.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CSWC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 33.9 | Neutral |
CSWC's weekly RSI is 50 (neutral) and its Stochastic is 34 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CSWC PE vs Financial Services Sector
| Metric | CSWC | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 6.1% above |
| PE % | 76 | 63 | 13 pts above |
CSWC is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CSWC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.2 | 1.3% above |
| 20 week MA | $23.9 | 1.5% below |
| 50 week MA | $23.2 | 1.2% above |
| 100 week MA | $22.5 | 4.5% above |
| 200 week MA | $22.5 | 4.3% above |
CSWC has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CSWC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.0 | $16.6 | -21% |
| 2021 | $16.6 | $25.3 | +53% |
| 2022 | $25.3 | $17.3 | -32% |
| 2023 | $17.3 | $23.7 | +37% |
| 2024 | $23.7 | $21.6 | -8.9% |
| 2025 | $21.6 | $21.9 | +1.6% |
| 2026 YTD | $21.9 | $23.5 | +7.2% |
CSWC has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.